Similar articles for PMID: 27363619

Year	Number of Results
2003	3
2004	2
2005	5
2006	5
2007	3
2008	4
2009	2
2010	6
2011	9
2012	10
2013	12
2014	15
2015	5
2016	9
2017	10
2018	12
2019	7
2020	9
2021	7
2022	10
2023	3
2024	0

1

Pozzobon T, Goldoni G, Viola A, Molon B. Pozzobon T, et al. Immunol Lett. 2016 Sep;177:6-15. doi: 10.1016/j.imlet.2016.06.006. Epub 2016 Jun 27. Immunol Lett. 2016. PMID: 27363619 Review.

2

CXCL12/CXCR4-axis dysfunctions: Markers of the rare immunodeficiency disorder WHIM syndrome.

Bachelerie F. Bachelerie F. Dis Markers. 2010;29(3-4):189-98. doi: 10.3233/DMA-2010-0736. Dis Markers. 2010. PMID: 21178277 Free PMC article. Review.

3

CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome.

Lagane B, Chow KY, Balabanian K, Levoye A, Harriague J, Planchenault T, Baleux F, Gunera-Saad N, Arenzana-Seisdedos F, Bachelerie F. Lagane B, et al. Blood. 2008 Jul 1;112(1):34-44. doi: 10.1182/blood-2007-07-102103. Epub 2008 Apr 24. Blood. 2008. PMID: 18436740 Free article.

4

WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.

Balabanian K, Lagane B, Pablos JL, Laurent L, Planchenault T, Verola O, Lebbe C, Kerob D, Dupuy A, Hermine O, Nicolas JF, Latger-Cannard V, Bensoussan D, Bordigoni P, Baleux F, Le Deist F, Virelizier JL, Arenzana-Seisdedos F, Bachelerie F. Balabanian K, et al. Blood. 2005 Mar 15;105(6):2449-57. doi: 10.1182/blood-2004-06-2289. Epub 2004 Nov 9. Blood. 2005. PMID: 15536153 Free article.

5

Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome.

Dotta L, Tassone L, Badolato R. Dotta L, et al. Curr Mol Med. 2011 Jun;11(4):317-25. doi: 10.2174/156652411795677963. Curr Mol Med. 2011. PMID: 21506920 Review.

6

CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.

de Wit RH, Heukers R, Brink HJ, Arsova A, Maussang D, Cutolo P, Strubbe B, Vischer HF, Bachelerie F, Smit MJ. de Wit RH, et al. J Pharmacol Exp Ther. 2017 Oct;363(1):35-44. doi: 10.1124/jpet.117.242735. Epub 2017 Aug 2. J Pharmacol Exp Ther. 2017. PMID: 28768817

7

Stromal-derived factor-1 abolishes constitutive apoptosis of WHIM syndrome neutrophils harbouring a truncating CXCR4 mutation.

Sanmun D, Garwicz D, Smith CI, Palmblad J, Fadeel B. Sanmun D, et al. Br J Haematol. 2006 Sep;134(6):640-4. doi: 10.1111/j.1365-2141.2006.06240.x. Epub 2006 Aug 9. Br J Haematol. 2006. PMID: 16899028 Free article.

8

Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.

Murphy PM, Heusinkveld L. Murphy PM, et al. Cytokine. 2018 Sep;109:2-10. doi: 10.1016/j.cyto.2017.12.022. Epub 2018 Feb 15. Cytokine. 2018. PMID: 29398278 Free PMC article. Review.

9

CXCR4 mutations in WHIM syndrome: a misguided immune system?

Diaz GA. Diaz GA. Immunol Rev. 2005 Feb;203:235-43. doi: 10.1111/j.0105-2896.2005.00226.x. Immunol Rev. 2005. PMID: 15661033 Review.

10

G protein-coupled receptor kinase-3-deficient mice exhibit WHIM syndrome features and attenuated inflammatory responses.

Tarrant TK, Billard MJ, Timoshchenko RG, McGinnis MW, Serafin DS, Foreman O, Esserman DA, Chao NJ, Lento WE, Lee DM, Patel D, Siderovski DP. Tarrant TK, et al. J Leukoc Biol. 2013 Dec;94(6):1243-51. doi: 10.1189/jlb.0213097. Epub 2013 Aug 9. J Leukoc Biol. 2013. PMID: 23935208 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

133 results

Results by year